|
|
|
Bath and Prosonix Sign Agreement for SAX Technology |
|
|
|
|
Written by Graham Ruecroft
|
|
Tuesday, 19 December 2006 12:55 |
The University of Bath (Bath, UK) and Prosonix Limited (Oxford, UK) are delighted to announce the signing of an exclusive agreement for the development and commercialisation of the University’s novel particle engineering technology Solution, Atomisation and Crystallization by Sonication (SAX).
|
|
Last Updated on Sunday, 18 January 2009 19:37 |
|
Prosonix and UCB Extend Co-Development Agreement |
|
|
|
|
Written by Graham Ruecroft
|
|
Tuesday, 19 December 2006 12:54 |
Prosonix Ltd (Oxford UK) and UCB SA (Braine l’Alleud, Belgium), are pleased to announce the extension of their Co-Development and Licensing Agreement for the utilization of Prosonix’ proprietary sonocrystallization technology across a range of its pharmaceutical products.
|
|
Last Updated on Sunday, 18 January 2009 19:41 |
|
|
Prosonix Launches New SAX Technology |
|
|
|
|
Written by Graham Ruecroft
|
|
Tuesday, 19 December 2006 12:53 |
Prosonix Limited (Oxford, UK) is delighted to announce an agreement with the University of Bath (Bath, UK) for the exclusive commercialisation of the University’s unique sonocrystallization particle engineering technology Solution Atomisation and Crystallization by Sonication (SAX TM). The agreement builds on 18 months of initial collaboration and technology evaluation between the parties. |
|
Last Updated on Sunday, 18 January 2009 19:41 |
|
Prosonix Shortlisted for CPHI 2006 Innovation Award |
|
|
|
|
Written by Graham Ruecroft
|
|
Tuesday, 19 December 2006 12:53 |
 Prosonix (Oxford UK) are delighted to announce that for the second year in succession, they have been short listed for the CPhI Worldwide Innovation Award, for their new SAXTM particle engineering technology, which has been under development in partnership with Dr Rob Price of the University of Bath (Bath, UK). This international peer recognition of the potential of SAXTM (Solution Atomization and Sonocrystallization) follows on from their CPhI Worldwide 2005 Innovation Award Gold Medal success for CrystalGEMTM, and confirms Prosonix’s status as an acknowledged world leader in the commercialisation of cutting edge technology in pharmaceutical ultrasonic process chemistry. |
|
Last Updated on Sunday, 18 January 2009 19:41 |
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
|
|
Page 5 of 9 |